These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3352794)
21. Summary of workshop on present knowledge of late effects of treatment on endocrine function. Sklar C; Nesbit M Cancer Clin Trials; 1981; 4 Suppl():21-3. PubMed ID: 7307223 [No Abstract] [Full Text] [Related]
22. [Adverse effects of concomitant chemoradiotherapy and their prevention and treatment]. Horová H; Soumarová R; Seneklová Z; Růzicková J Cas Lek Cesk; 2003; 142 Suppl 1():53-6. PubMed ID: 12924053 [TBL] [Abstract][Full Text] [Related]
23. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D; Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811 [TBL] [Abstract][Full Text] [Related]
24. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop. Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787 [No Abstract] [Full Text] [Related]
25. [Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient]. Besse B; Soria JC Rev Prat; 2007 Feb; 57(4):429-40; quiz 440. PubMed ID: 17455746 [No Abstract] [Full Text] [Related]
26. Correction to "Congestive heart failure after treatment for Wilms' tumor". Green DM; Grigoriev YA; Nan B; Takashima JR; Norkool PA; D'Angio GJ; Breslow NE J Clin Oncol; 2003 Jun; 21(12):2447-8. PubMed ID: 12805354 [No Abstract] [Full Text] [Related]
27. [Where, in our current knowledge, is the place for cancer prevention?]. García García G An R Acad Nac Med (Madr); 1989; 106(2):289-310. PubMed ID: 2604033 [No Abstract] [Full Text] [Related]
28. [Late adverse effects of therapy for malignant diseases in childhood]. Gaedicke G Internist (Berl); 1994 Mar; 35(3):213-8. PubMed ID: 8175284 [No Abstract] [Full Text] [Related]
29. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N; Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568 [TBL] [Abstract][Full Text] [Related]
30. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial. Danson S; Ranson M; Denneny O; Cummings J; Ward TH Cancer Chemother Pharmacol; 2007 Nov; 60(6):851-61. PubMed ID: 17333193 [TBL] [Abstract][Full Text] [Related]
31. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448 [TBL] [Abstract][Full Text] [Related]
32. Carcinogenic, mutagenic, teratogenic workshop. Suit H; Hall E; Frei E Cancer Clin Trials; 1981; 4 Suppl():37-41. PubMed ID: 7307224 [No Abstract] [Full Text] [Related]
33. Future development of amifostine as a radioprotectant. Werner-Wasik M Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272 [TBL] [Abstract][Full Text] [Related]
34. Phase I study of topotecan and radiation therapy in advanced cervical cancer. Dunton CJ; King SA; Neufeld J; Tolosa J; Perez G; Avila A; Underhill K Gynecol Oncol; 2002 Apr; 85(1):185-7. PubMed ID: 11925142 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381 [TBL] [Abstract][Full Text] [Related]
36. In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice. Chastagner P; Merlin JL; Marchal C; Hoffstetter S; Barberi-Heyob M; Vassal G; Duprez A Clin Cancer Res; 2000 Aug; 6(8):3327-33. PubMed ID: 10955820 [TBL] [Abstract][Full Text] [Related]
37. Cervical cancer 2: treatment options and side-effects. Jefferies H Nurs Times; 2008 Nov 11-17; 104(45):26-7. PubMed ID: 19051685 [TBL] [Abstract][Full Text] [Related]
38. Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Seegenschmiedt MH Strahlenther Onkol; 1998 Nov; 174 Suppl 3():25-9. PubMed ID: 9830452 [TBL] [Abstract][Full Text] [Related]
39. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial. Munshi A; Pandey KC; Susheela SP Radiother Oncol; 2006 Jan; 78(1):109-10; author reply 108-9. PubMed ID: 16307815 [No Abstract] [Full Text] [Related]
40. [Long-term sequelae of malignant tumors in childhood: consequences of late side-effects]. Peretz NM; Goldberg H; Kuten A; Meller I; Krivoi E; Lorber A; Bentur L; Lightman A; Gorenberg V; Ben Arush-Weyl M Harefuah; 2001 Feb; 140(2):95-100, 192, 191. PubMed ID: 11242936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]